Related Experiment Video
Updated: Jan 31, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Ethical considerations of cellular immunotherapy for cancer
Sang-Sang Ren1, Jing-Wen Deng2, Meng Hong2
1Health Policy and Hospital Management Research Center, Department of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Abstract:
With the rapid development of immunology, molecular biology, and associated technologies such as next-generation sequencing, cellular immunotherapy has recently become the fourth major cancer treatment. Immunotherapies based on T cells, natural killer cells, and dendritic cells play key roles in cancer immunotherapy. However, their application in clinical practice raises several ethical issues. Thus, studies should focus on proper adherence to basic ethical principles that can effectively guide and solve related clinical problems in the course of treatment, improve treatment effects, and protect the rights and interests of patients. In this review, we discuss cellular immunotherapy-related ethical issues and highlight the ethical practices and current status of cellular immunotherapy in China. These considerations may supplement existing ethical standards in cancer immunotherapy.
Related Concept Videos
Ethics in Research
Tumor Immunotherapy
Ethics and Bioethics
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas II
Ethical Standards I
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

